Five Oceans Advisors raised its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 22.2% during the 4th quarter, according to the company in its most recent Form 13F filing ...
Some results have been hidden because they may be inaccessible to you